Amended Statement of Ownership (sc 13g/a)
February 16 2021 - 4:16PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G/A
UNDER THE SECURITIES EXCHANGE ACT OF
1934
(Amendment No. 1)*
Galera Therapeutics, Inc.
(Name of Issuer)
Common Stock, $0.001 par value
(Title of Class of Securities)
36338D108
(CUSIP Number)
December 31, 2020
(Date of Event Which Requires Filing
of This Statement)
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
|
*
|
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
|
The information required in the remainder of this cover page
shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
|
CUSIP No. 36338D108
|
Page 2 of 14
|
|
1.
|
Name of reporting persons
Venrock Healthcare Capital Partners III, L.P.
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
x1
(b) ¨
|
|
3.
|
SEC USE ONLY
|
|
4.
|
Citizenship or Place of Organization
Delaware
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
5.
|
Sole Voting Power
0
|
|
6.
|
Shared Voting Power
917,8602
|
|
7.
|
Sole Dispositive Power
0
|
|
8.
|
Shared Dispositive Power
917,8602
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
917,8602
|
|
10.
|
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
3.7%3
|
|
12.
|
Type of Reporting Person (See Instructions)
PN
|
|
1
|
Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
|
|
2
|
Consists of (i) 414,047 shares held by Venrock Healthcare Capital Partners III, L.P., (ii) 41,396 shares held by VHCP Co-Investment Holdings III, LLC and (iii) 462,417 shares held by Venrock Healthcare Capital Partners EG, L.P.
|
|
3
|
This percentage is calculated based upon 24,951,352 shares of the Issuer’s Common Stock outstanding as of November 5, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2020.
|
|
CUSIP No. 36338D108
|
Page 3 of 14
|
|
1.
|
Name of reporting persons
VHCP Co-Investment Holdings III, LLC
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
x1
(b) ¨
|
|
3.
|
SEC USE ONLY
|
|
4.
|
Citizenship or Place of Organization
Delaware
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
5.
|
Sole Voting Power
0
|
|
6.
|
Shared Voting Power
917,8602
|
|
7.
|
Sole Dispositive Power
0
|
|
8.
|
Shared Dispositive Power
917,8602
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
917,8602
|
|
10.
|
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
3.7%3
|
|
12.
|
Type of Reporting Person (See Instructions)
OO
|
|
1
|
Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
|
|
2
|
Consists of (i) 414,047 shares held by Venrock Healthcare Capital Partners III, L.P., (ii) 41,396 shares held by VHCP Co-Investment Holdings III, LLC and (iii) 462,417 shares held by Venrock Healthcare Capital Partners EG, L.P.
|
|
3
|
This percentage is calculated based upon 24,951,352 shares of the Issuer’s Common Stock outstanding as of November 5, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2020.
|
|
CUSIP No. 36338D108
|
Page 4 of 14
|
|
1.
|
Name of reporting persons
Venrock Healthcare Capital Partners EG, L.P.
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
x1
(b) ¨
|
|
3.
|
SEC USE ONLY
|
|
4.
|
Citizenship or Place of Organization
Delaware
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
5.
|
Sole Voting Power
0
|
|
6.
|
Shared Voting Power
917,8602
|
|
7.
|
Sole Dispositive Power
0
|
|
8.
|
Shared Dispositive Power
917,8602
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
917,8602
|
|
10.
|
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
3.7%3
|
|
12.
|
Type of Reporting Person (See Instructions)
PN
|
|
1
|
Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
|
|
2
|
Consists of (i) 414,047 shares held by Venrock Healthcare Capital Partners III, L.P., (ii) 41,396 shares held by VHCP Co-Investment Holdings III, LLC and (iii) 462,417 shares held by Venrock Healthcare Capital Partners EG, L.P.
|
|
3
|
This percentage is calculated based upon 24,951,352 shares of the Issuer’s Common Stock outstanding as of November 5, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2020.
|
|
CUSIP No. 36338D108
|
Page 5 of 14
|
|
1.
|
Name of reporting persons
VHCP Management III, LLC
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) x1
(b) ¨
|
|
3.
|
SEC USE ONLY
|
|
4.
|
Citizenship or Place of Organization
Delaware
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
5.
|
Sole Voting Power
0
|
|
6.
|
Shared Voting Power
917,8602
|
|
7.
|
Sole Dispositive Power
0
|
|
8.
|
Shared Dispositive Power
917,8602
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
917,8602
|
|
10.
|
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
3.7%3
|
|
12.
|
Type of Reporting Person (See Instructions)
OO
|
|
1
|
Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
|
|
2
|
Consists of (i) 414,047 shares held by Venrock Healthcare Capital Partners III, L.P., (ii) 41,396 shares held by VHCP Co-Investment Holdings III, LLC and (iii) 462,417 shares held by Venrock Healthcare Capital Partners EG, L.P.
|
|
3
|
This percentage is calculated based upon 24,951,352 shares of the Issuer’s Common Stock outstanding as of November 5, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2020.
|
|
CUSIP No. 36338D108
|
Page 6 of 14
|
|
1.
|
Name of reporting persons
VHCP Management EG, LLC
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) x1
(b) ¨
|
|
3.
|
SEC USE ONLY
|
|
4.
|
Citizenship or Place of Organization
Delaware
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
5.
|
Sole Voting Power
0
|
|
6.
|
Shared Voting Power
917,8602
|
|
7.
|
Sole Dispositive Power
0
|
|
8.
|
Shared Dispositive Power
917,8602
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
917,8602
|
|
10.
|
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
3.7%3
|
|
12.
|
Type of Reporting Person (See Instructions)
OO
|
|
1
|
Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
|
|
2
|
Consists of (i) 414,047 shares held by Venrock Healthcare Capital Partners III, L.P., (ii) 41,396 shares held by VHCP Co-Investment Holdings III, LLC and (iii) 462,417 shares held by Venrock Healthcare Capital Partners EG, L.P.
|
|
3
|
This percentage is calculated based upon 24,951,352 shares of the Issuer’s Common Stock outstanding as of November 5, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2020.
|
|
CUSIP No. 36338D108
|
Page 7 of 14
|
|
1.
|
Name of Reporting Persons
Shah, Nimish
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) x1
(b) ¨
|
|
3.
|
SEC USE ONLY
|
|
4.
|
Citizenship or Place of Organization
United States
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
5.
|
Sole Voting Power
0
|
|
6.
|
Shared Voting Power
917,8602
|
|
7.
|
Sole Dispositive Power
0
|
|
8.
|
Shared Dispositive Power
917,8602
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
917,8602
|
|
10.
|
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
3.7%3
|
|
12.
|
Type of Reporting Person (See Instructions)
IN
|
|
1
|
Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
|
|
2
|
Consists of (i) 414,047 shares held by Venrock Healthcare Capital Partners III, L.P., (ii) 41,396 shares held by VHCP Co-Investment Holdings III, LLC and (iii) 462,417 shares held by Venrock Healthcare Capital Partners EG, L.P.
|
|
3
|
This percentage is calculated based upon 24,951,352 shares of the Issuer’s Common Stock outstanding as of November 5, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2020.
|
|
CUSIP No. 36338D108
|
Page 8 of 14
|
|
1.
|
Name of Reporting Persons
Koh, Bong
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) x1
(b) ¨
|
|
3.
|
SEC USE ONLY
|
|
4.
|
Citizenship or Place of Organization
United States
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With:
|
5.
|
Sole Voting Power
0
|
|
6.
|
Shared Voting Power
917,8602
|
|
7.
|
Sole Dispositive Power
0
|
|
8.
|
Shared Dispositive Power
917,8602
|
|
9.
|
Aggregate Amount Beneficially
Owned by Each Reporting Person
917,8602
|
|
10.
|
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
3.7%3
|
|
12.
|
Type of Reporting Person (See Instructions)
IN
|
|
1
|
Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A.
|
|
2
|
Consists of (i) 414,047 shares held by Venrock Healthcare Capital Partners III, L.P., (ii) 41,396 shares held by VHCP Co-Investment Holdings III, LLC and (iii) 462,417 shares held by Venrock Healthcare Capital Partners EG, L.P.
|
|
3
|
This percentage is calculated based upon 24,951,352 shares of the Issuer’s Common Stock outstanding as of November 5, 2020, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2020.
|
|
CUSIP No. 36338D108
|
Page 9 of 14
|
Introductory Note: This Schedule 13G/A is filed on behalf of
Venrock Healthcare Capital Partners III, L.P., a limited partnership organized under the laws of the State of Delaware (“VHCP
III LP”), VHCP Co-Investment Holdings III, LLC, a limited liability company organized under the laws of the State of Delaware
(“VHCP Co-Investment III”), Venrock Healthcare Capital Partners EG, L.P., a limited partnership organized under the
laws of the State of Delaware (“VHCP EG”), VHCP Management III, LLC, a limited liability company organized under the
laws of the State of Delaware (“VHCP Management III”), VHCP Management EG, LLC, a limited liability company organized
under the laws of the State of Delaware (“VHCP Management EG” and collectively with VHCP III LP, VHCP Co-Investment
III, VHCP EG and VHCP Management III, the “Venrock Entities”), Nimish Shah (“Shah”) and Bong Koh (“Koh”)
in respect of Common Stock of Galera Therapeutics, Inc.
Item 1.
Galera Therapeutics, Inc.
|
|
(b)
|
Address of Issuer’s Principal Executive Offices
|
2 W. Liberty Boulevard #100
Malvern, Pennsylvania 19355
Item 2.
|
|
(a)
|
Name of Person Filing
|
Venrock Healthcare Capital Partners III, L.P.
VHCP Co-Investment Holdings III, LLC
Venrock Healthcare Capital Partners EG, L.P.
VHCP Management III, LLC
VHCP Management EG, LLC
Nimish Shah
Bong Koh
|
|
(b)
|
Address of Principal Business Office or, if none, Residence
|
|
New York Office:
|
|
Palo Alto Office:
|
|
|
|
|
|
|
|
7 Bryant Park
|
|
3340 Hillview Avenue
|
|
|
23rd Floor
|
|
Palo Alto, CA 94304
|
|
|
New York, NY 10018
|
|
|
|
All of the Venrock Entities were organized in Delaware. The
individuals are both United States citizens.
|
|
(d)
|
Title of Class of Securities
|
Common Stock, par value $0.001 per share
CUSIP No. 36338D108
|
Page 10 of 14
|
|
Item 3.
|
If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
|
Not applicable
|
|
(a)
|
Amount Beneficially Owned as of December 31, 2020:
|
|
Venrock Healthcare Capital Partners III, L.P.
|
|
917,860
|
(1)
|
|
VHCP Co-Investment Holdings III, LLC
|
|
917,860
|
(1)
|
|
Venrock Healthcare Capital Partners EG, L.P.
|
|
917,860
|
(1)
|
|
VHCP Management III, LLC
|
|
917,860
|
(1)
|
|
VHCP Management EG, LLC
|
|
917,860
|
(1)
|
|
Nimish Shah
|
|
917,860
|
(1)
|
|
Bong Koh
|
|
917,860
|
(1)
|
|
|
(b)
|
Percent of Class as of December 31, 2020:
|
|
Venrock Healthcare Capital Partners III, L.P.
|
|
3.7
|
%
|
|
VHCP Co-Investment Holdings III, LLC
|
|
3.7
|
%
|
|
Venrock Healthcare Capital Partners EG, L.P.
|
|
3.7
|
%
|
|
VHCP Management III, LLC
|
|
3.7
|
%
|
|
VHCP Management EG, LLC
|
|
3.7
|
%
|
|
Nimish Shah
|
|
3.7
|
%
|
|
Bong Koh
|
|
3.7
|
%
|
|
|
(c)
|
Number of shares as to which the person has, as of December 31, 2020:
|
|
|
(i)
|
Sole power to vote or to direct the vote
|
|
Venrock Healthcare Capital Partners III, L.P.
|
|
0
|
|
VHCP Co-Investment Holdings III, LLC
|
|
0
|
|
Venrock Healthcare Capital Partners EG, L.P.
|
|
0
|
|
VHCP Management III, LLC
|
|
0
|
|
VHCP Management EG, LLC
|
|
0
|
|
Nimish Shah
|
|
0
|
|
Bong Koh
|
|
0
|
|
CUSIP No. 36338D108
|
Page 11 of 14
|
|
|
(ii)
|
Shared power to vote or to direct the vote
|
|
Venrock
Healthcare Capital Partners III, L.P.
|
|
917,860
|
(1)
|
|
VHCP Co-Investment Holdings
III, LLC
|
|
917,860
|
(1)
|
|
Venrock Healthcare Capital
Partners EG, L.P.
|
|
917,860
|
(1)
|
|
VHCP Management III,
LLC
|
|
917,860
|
(1)
|
|
VHCP Management EG,
LLC
|
|
917,860
|
(1)
|
|
Nimish Shah
|
|
917,860
|
(1)
|
|
Bong Koh
|
|
917,860
|
(1)
|
|
|
(iii)
|
Sole power to dispose or to direct the disposition of
|
|
Venrock
Healthcare Capital Partners III, L.P.
|
|
0
|
|
|
VHCP Co-Investment Holdings
III, LLC
|
|
0
|
|
|
Venrock Healthcare Capital
Partners EG, L.P.
|
|
0
|
|
|
VHCP Management III,
LLC
|
|
0
|
|
|
VHCP Management EG,
LLC
|
|
0
|
|
|
Nimish Shah
|
|
0
|
|
|
Bong Koh
|
|
0
|
|
|
|
(iv)
|
Shared power to dispose or to direct the disposition of
|
|
Venrock
Healthcare Capital Partners III, L.P.
|
|
917,860
|
(1)
|
|
VHCP Co-Investment Holdings
III, LLC
|
|
917,860
|
(1)
|
|
Venrock Healthcare Capital
Partners EG, L.P.
|
|
917,860
|
(1)
|
|
VHCP Management III,
LLC
|
|
917,860
|
(1)
|
|
VHCP Management EG,
LLC
|
|
917,860
|
(1)
|
|
Nimish Shah
|
|
917,860
|
(1)
|
|
Bong Koh
|
|
917,860
|
(1)
|
|
(1)
|
Consists of (i) 414,047 shares held by Venrock Healthcare Capital Partners III, L.P., (ii) 41,396 shares held by VHCP Co-Investment Holdings III, LLC and (iii) 462,417 shares held by Venrock Healthcare Capital Partners EG, L.P. VHCP Management III, LLC is the general partner of Venrock Healthcare Capital Partners III, L.P. and the manager of VHCP Co-Investment Holdings III, LLC. VHCP Management EG, LLC is the general partner of Venrock Healthcare Capital Partners EG, L.P. Messrs. Shah and Koh are the voting members of VHCP Management III, LLC and VHCP Management EG, LLC.
|
|
Item 5.
|
Ownership of Five Percent or Less of a Class
|
If this statement is being filed to report the fact that as
of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities,
check the following x.
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person
|
Not Applicable
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
|
Not Applicable
|
CUSIP No. 36338D108
|
Page 12 of 14
|
|
Item 8.
|
Identification and Classification of Members of the Group
|
Not Applicable
|
Item 9.
|
Notice of Dissolution of a Group
|
Not Applicable
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing
or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant
in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
|
CUSIP No. 36338D108
|
Page 13 of 14
|
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 16, 2021
|
Venrock Healthcare Capital Partners III, L.P.
|
|
Venrock Healthcare Capital Partners EG, L.P.
|
|
|
|
|
|
|
|
By:
|
VHCP Management III, LLC
|
|
By:
|
VHCP Management EG, LLC
|
|
Its:
|
General Partner
|
|
Its:
|
General Partner
|
|
|
|
|
|
|
|
By:
|
/s/ David L. Stepp
|
|
By:
|
/s/ David L. Stepp
|
|
|
Name:
|
David L. Stepp
|
|
|
Name:
|
David L. Stepp
|
|
|
Its:
|
Authorized Signatory
|
|
|
Its:
|
Authorized Signatory
|
|
|
|
|
|
VHCP Co-Investment Holdings III, LLC
|
|
VHCP Management EG, LLC
|
|
|
|
|
|
|
|
By:
|
VHCP Management III, LLC
|
|
|
|
|
Its:
|
Manager
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ David L. Stepp
|
|
By:
|
/s/ David L. Stepp
|
|
|
Name:
|
David L. Stepp
|
|
|
Name:
|
David L. Stepp
|
|
|
Its:
|
Authorized Signatory
|
|
|
Its:
|
Authorized Signatory
|
|
|
|
|
|
VHCP Management III, LLC
|
|
Nimish Shah
|
|
|
|
|
|
|
|
By:
|
/s/ David L. Stepp
|
|
By:
|
/s/ David L. Stepp
|
|
|
Name:
|
David L. Stepp
|
|
|
David L. Stepp, as attorney-in-fact
|
|
|
Its:
|
Authorized Signatory
|
|
|
|
|
|
|
|
|
|
|
|
Bong Koh
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ David L. Stepp
|
|
|
|
|
|
David L. Stepp, as attorney-in-fact
|
|
CUSIP No. 36338D108
|
Page 14 of 14
|
EXHIBITS
|
A:
|
Joint Filing Agreement (incorporated by reference to Exhibit A to Schedule 13G filed on November 4, 2020)
|
|
B:
|
Power of Attorney for Nimish Shah (incorporated by reference to Exhibit B to Schedule 13G filed on November 4, 2020)
|
|
C:
|
Power of Attorney for Bong Koh (incorporated by reference to Exhibit C to Schedule 13G filed on November 4, 2020)
|
Galera Therapeutics (NASDAQ:GRTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Galera Therapeutics (NASDAQ:GRTX)
Historical Stock Chart
From Apr 2023 to Apr 2024
